NK-92 cells engineered with anti-CD33 chimeric antigen receptors (CAR) for the treatment of acute myeloid leukemia (AML) Meeting Abstract


Authors: Rafiq, S.; Purdon, T. J.; Schultz, L.; Klingemann, H.; Brentjens, R. J.
Abstract Title: NK-92 cells engineered with anti-CD33 chimeric antigen receptors (CAR) for the treatment of acute myeloid leukemia (AML)
Meeting Title: ISCT 2015
Journal Title: Cytotherapy
Volume: 17
Issue: 6 Suppl.
Meeting Dates: 2015 May 27-30
Meeting Location: Las Vegas, NV
ISSN: 1465-3249
Publisher: Elsevier Science Ltd.  
Date Published: 2015-06-01
Start Page: S23
Language: English
ACCESSION: WOS:000354142700063
PROVIDER: Thomson Reuters Web of Scienceā„¢
PROVIDER: wos
DOI: 10.1016/j.jcyt.2015.03.367
Notes: Meeting Abstract: 61 -- Source: Wos
Altmetric Score
MSK Authors
  1. Renier J Brentjens
    195 Brentjens
  2. Sarwish Rafiq
    12 Rafiq
  3. Terence John Purdon
    35 Purdon